tert-Butyl4-(oxan-4-ylamino)piperidine-1-carboxylate
95%
- Product Code: 87418
CAS:
710977-70-1
Molecular Weight: | 284.39 g./mol | Molecular Formula: | C₁₅H₂₈N₂O₃ |
---|---|---|---|
EC Number: | MDL Number: | MFCD12694765 | |
Melting Point: | Boiling Point: | ||
Density: | Storage Condition: | 2-8°C, dry, airtight |
Product Description:
This compound is primarily utilized in the field of medicinal chemistry as an intermediate in the synthesis of biologically active molecules. It is often employed in the development of pharmaceutical compounds, particularly in the creation of potential drug candidates targeting neurological disorders. Its structural features make it a valuable building block for designing molecules that interact with specific receptors or enzymes in the central nervous system. Researchers also explore its use in optimizing pharmacokinetic properties, such as bioavailability and metabolic stability, in drug discovery programs. Additionally, it may serve as a key component in the preparation of compounds for preclinical studies, aiding in the identification of novel therapeutic agents.
Sizes / Availability / Pricing:
Size (g) | Availability | Price | Quantity |
---|---|---|---|
0.100 | 10-20 days | ฿9,351.00 |
+
-
|
tert-Butyl4-(oxan-4-ylamino)piperidine-1-carboxylate
This compound is primarily utilized in the field of medicinal chemistry as an intermediate in the synthesis of biologically active molecules. It is often employed in the development of pharmaceutical compounds, particularly in the creation of potential drug candidates targeting neurological disorders. Its structural features make it a valuable building block for designing molecules that interact with specific receptors or enzymes in the central nervous system. Researchers also explore its use in optimizing pharmacokinetic properties, such as bioavailability and metabolic stability, in drug discovery programs. Additionally, it may serve as a key component in the preparation of compounds for preclinical studies, aiding in the identification of novel therapeutic agents.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :